ARCHIVES

FDA Staff Efforts To Issue Warning Letters On Procrit Ads Were Stopped By Counsel.

This article is from The Cancer Letter archive.

Vol. 34 No. 18 | May 9, 2008

Download PDF Visit The Full Archive

Related Articles

NCI Pilot to Speed Phase III Trials Deemed Unsuccessful, Will Be Shut Down

November 22, 2002

Switch To NTP Holds Down Entry Of New Compounds; Obey Supports NCI On Need For More Positions

March 16, 1979

Imaging Technique Identifies Consequences Of Mutation

February 24, 2012

Herceptin Regimen Minus Adriamycin Increases Survival With Less Toxicity

October 28, 2011

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998

House Committee Proposes $750 Mil. Increase For NIH, supports Bypass

May 4, 1990